recurrent head and neck carcinoma
Showing 1 - 8 of 8
Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint
Not yet recruiting
- Recurrent Head and Neck Cancer
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Recurrent Head and Neck Carcinoma Trial in Houston (Intensity-Modulated Radiation Therapy, Proton Radiation, Stereotactic Body
Recruiting
- Recurrent Head and Neck Carcinoma
- Intensity-Modulated Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 16, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Recurrent Head and Neck Carcinoma Trial in Philadelphia (radiation, drug, procedure)
Active, not recruiting
- Recurrent Head and Neck Carcinoma
- Brachytherapy
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 7, 2020
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
FGFR Gene Amplification, FGFR1 Gene Amplification, FGFR2 Gene Amplification Trial in Chicago (BGJ398)
Terminated
- FGFR Gene Amplification
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 9, 2019
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in
Completed
- Head and Neck Squamous Cell Carcinoma
- +13 more
- Laboratory Biomarker Analysis
- +2 more
-
Palo Alto, California
- +4 more
Sep 14, 2017